Novel Orally Available Degrader to Target Lck in T-Cell Acute Lymphoblastic Leukemia

被引：0
|
作者：
Jeong, Na-Rae [1 ]
Lim, Ye Seul [1 ]
Yoo, Sun-Mi [1 ]
Kim, Han Wool [1 ]
Kim, So Hyuk [1 ]
Choi, Ae-Ran [1 ]
Kim, Dong-Wook [2 ]
Lee, Song Hee [1 ]
机构：
[1] Ubix Therapeut, Seoul, South Korea
[2] Uijeongbu Eulji Med Ctr, Uijeoungbu Si, South Korea
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185778
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia
    Jarusiewicz, Jamie A.
    Yoshimura, Satoshi
    Actis, Marisa
    Li, Yong
    Fu, Xiang
    Yang, Lei
    Narina, Shilpa
    Pruett-Miller, Shondra M.
    Zhou, Suiping
    Wang, Xusheng
    High, Anthony A.
    Nishiguchi, Gisele
    Yang, Jun J.
    Rankovic, Zoran
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (14) : 11868 - 11884
  • [2] Development of Proteolytic Targeting Chimeras to Target Lck in T-Cell Acute Lymphoblastic Leukemia
    Hu, Jianzhong
    Jarusiewicz, Jamie
    Min, Jaeki
    Yang, Lei
    Chepyala, Divyabharathi
    Actis, Marisa
    Rowland, Lauren
    Du, Guoqing
    Smart, Brandon
    Maxwell, Dylan
    Xie, Boer
    Yoshimura, Satoshi
    Peng, Junmin
    Teachey, David
    Rankovic, Zoran
    Yang, Jun J.
    [J]. BLOOD, 2021, 138
  • [3] MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia
    Astolfi, Annalisa
    Vendemini, Francesca
    Urbini, Milena
    Melchionda, Fraia
    Masetti, Riccardo
    Franzoni, Monica
    Libri, Virginia
    Serravalle, Salvatore
    Togni, Marco
    Paone, Giuseppina
    Montemurro, Luca
    Bressanin, Daniela
    Chiarini, Francesca
    Martelli, Alberto M.
    Tonelli, Roberto
    Pession, Andrea
    [J]. ONCOTARGET, 2014, 5 (01) : 120 - 130
  • [4] Notch, a unifying target in T-cell acute lymphoblastic leukemia?
    Screpanti, I
    Bellavia, D
    Campese, AF
    Frati, L
    Gulino, A
    [J]. TRENDS IN MOLECULAR MEDICINE, 2003, 9 (01) : 30 - 35
  • [5] Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia
    Serafin, Valentina
    Capuzzo, Giorgia
    Milani, Gloria
    Minuzzo, Sonia Anna
    Pinazza, Marica
    Bortolozzi, Roberta
    Bresolin, Silvia
    Porcu, Elena
    Frasson, Chiara
    Indraccolo, Stefano
    Basso, Giuseppe
    Accordi, Benedetta
    [J]. BLOOD, 2017, 130 (25) : 2750 - 2761
  • [6] T-cell acute lymphoblastic leukemia
    Raetz, Elizabeth A.
    Teachey, David T.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 580 - 588
  • [7] T-cell acute lymphoblastic leukemia
    Chiaretti, Sabina
    Foa, Robin
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 160 - 162
  • [8] Novel biological insights in T-cell acute lymphoblastic leukemia
    Durinck, Kaat
    Goossens, Steven
    Peirs, Sofie
    Wallaert, Annelynn
    Van Loocke, Wouter
    Matthijssens, Filip
    Pieters, Tim
    Milani, Gloria
    Lammens, Tim
    Rondou, Pieter
    Van Roy, Nadine
    De Moerloose, Barbara
    Benoit, Yves
    Haigh, Jody
    Speleman, Frank
    Poppe, Bruce
    Van Vlierberghe, Pieter
    [J]. EXPERIMENTAL HEMATOLOGY, 2015, 43 (08) : 625 - 639
  • [9] Novel insights into the development of T-cell acute lymphoblastic leukemia
    Staal F.J.T.
    Van Dongen J.J.M.
    Langerak A.W.
    [J]. Current Hematologic Malignancy Reports, 2007, 2 (3) : 176 - 182
  • [10] DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
    Sexauer, Amy N.
    Alexe, Gabriela
    Gustafsson, Karin
    Zanetakos, Elizabeth
    Milosevic, Jelena
    Ayres, Mary
    Gandhi, Varsha
    Pikman, Yana
    Stegmaier, Kimberly
    Sykes, David B.
    [J]. BLOOD ADVANCES, 2023, 7 (21) : 6685 - 6701
12345